Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND study
2025 Kalogeropoulos, A; Hameed, I; Anker, S; Bayes-Genis, A; Bohm, M; Budden, J; Cleland, J; Coats, A; Ezekowitz, J; Filippatos, G; Goudev, A; Khan, M; Lindenfeld, J; Lund, L; Merkely, B; Mentz, R; Metra, M; Moutchia, J; Perrin, A; Ponikowski, P; Priest, E; Rossignol, P; Senni, M; Shaver, C; Waechter, S; Weir, M; Pitt, B; Butler, J
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure
2025 Vaduganathan, M; Claggett, B; Kulac, I; Miao, Z; Desai, A; Jhund, P; Henderson, A; Brinker, M; Lay-Flurrie, J; Viswanathan, P; Scheerer, M; Lage, A; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Mcmurray, J; Solomon, S
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial
2025 Butt, J; Jhund, P; Henderson, A; Claggett, B; Desai, A; Lam, C; Brinker, M; Schloemer, P; Viswanathan, P; Lage, A; Rohwedder, K; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study
2025 Greene, S; Corda, S; Mcmullan, C; Palombo, G; Schooss, C; Vlajnic, V; Walkamp, K; Senni, M
Azygos vein icd lead implantation lowers defibrillation threshold in a patient with hypertrophic cardiomyopathy
2021 Quarta, G; Ferrari, P; Giammarresi, A; Malanchini, G; Leidi, C; Senni, M; De Filippo, P
Economic Evaluation of Patiromer in Patients with Concomitant Heart Failure and Chronic Kidney Disease in Italy
2025 Senni, M; Paoletti, E; Stawowczyk, E; Hale, M; De Arellano, A
Ultrasound Assessment of Venous and Pulmonary Congestion in Left Ventricular Assist Devices Patients
2025 Iacovoni, A; Giaccherini, C; Paris, S; Abete, R; Vittori, C; Inciardi, R; Zucchetti, O; Terzi, A; Senni, M
Safety and tolerability of sacubitril/valsartan in chronic heart failure and reduced ejection fraction: Results from the open-label extension of the PARADIGM-HF study
2025 Senni, M; Paruchuru, P; Shi, V; Bohm, M
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction The FINEARTS-HF Randomized Clinical Trial
2025 Desai, A; Jhund, P; Vaduganathan, M; Claggett, B; Cunningham, J; Pabon, M; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Amarante, F; Lay-Flurrie, J; Scheerer, M; Lage, A; Mcmurray, J; Solomon, S
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model: A Secondary Analysis of FINEARTS-HF
2025 Mcdowell, K; Docherty, K; Campbell, R; Henderson, A; Jhund, P; Claggett, B; Desai, A; Lay-Flurrie, J; Hofmeister, L; Scalise, A; Lam, C; Petrie, M; Schou, M; Senni, M; Shah, S; Udell, J; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trials
2025 Docherty, K; Buendia Lopez, R; Folkvaljon, F; Boer, R; Chen, J; Hammarstedt, A; Kitzman, D; Kosiborod, M; Langkilde, A; Reicher, B; Senni, M; Wilderäng, U; Verma, S; Cowie, M; Solomon, S; Mcmurray, J
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
2025 Saldarriaga, C; Zannad, F; Mcmullan, C; Xing, A; Gates, D; Anstrom, K; Bonaca, M; Corda, S; Ezekowitz, J; Lam, C; Lewis, E; Lindenfeld, J; Mentz, R; O'Connor, C; Patel, M; Ponikowski, P; Reddy, Y; Rosano, G; Senni, M; Udelson, J; Voors, A; Butler, J
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease
2025 Ostrominski, J; Claggett, B; Miao, Z; Filippatos, G; Desai, A; Jhund, P; Henderson, A; Brinker, M; Schloemer, P; Viswanathan, P; Lage, A; Rohwedder, K; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Rossing, P; Ruilope, L; Anker, S; Pitt, B; Agarwal, R; Mcmurray, J; Solomon, S; Vaduganathan, M
Finerenone and Atrial Fibrillation in Heart Failure A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial
2025 Matsumoto, S; Henderson, A; Jhund, P; Bauersachs, J; Chioncel, O; Claggett, B; Comin-Colet, J; Desai, A; Filippatos, G; Lam, C; Pitt, B; Scheerer, M; Lay-Flurrie, J; Amarante, F; Brinker, M; Schou, M; Senni, M; Shah, S; Voors, A; Zannad, F; Zieroth, S; Vaduganathan, M; Solomon, S; Mcmurray, J
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry)
2025 Paolillo, S; Basile, C; Marzano, F; Bruzzese, D; Agostoni, P; Mattavelli, I; Aloisio, A; Ameri, P; Solimano, M; Brunetti, N; Calabro, P; Cesaro, A; Cameli, M; Mandoli, G; Carluccio, E; Belardinelli, C; Carugo, S; Casalino, L; Chiuini, E; Cosmi, D; Dini, F; Di Santo, M; Esposito, G; Ferrara, F; Fierro, M; Galasso, G; Gallo, L; Rispoli, A; Gargiulo, P; Grigioni, F; Segreti, A; Guarnaccia, F; Guarnaccia, N; Guerra, F; Cicchirillo, E; Indolfi, C; Larcher, M; Lillo, A; Metra, M; Montisci, R; Marchetti, M; Nodari, S; Fioretti, F; Nardi, E; Oliviero, U; Palazzuoli, A; Patti, G; Pepe, M; Pacelli, F; Perrone Filardi, F; Putorti, G; Santoro, G; Senni, M; D'Elia, E; Severino, P; D'Amato, A; Soriano, S; Sinagra, G; Rossi, M; Franzese, M; Smaldone, G; Zito, G; Perrone Filardi, P
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: Part 2-care pathways, treatment, and follow-up
2022 Baigent, C; Windecker, S; Andreini, D; Arbelo, E; Barbato, E; Bartorelli, A; Baumbach, A; Behr, E; Berti, S; Bueno, H; Capodanno, D; Cappato, R; Chieffo, A; Collet, J; Cuisset, T; De Simone, G; Delgado, V; Dendale, P; Dudek, D; Edvardsen, T; Elvan, A; González-Juanatey, J; Gori, M; Grobbee, D; Guzik, T; Halvorsen, S; Haude, M; Heidbuchel, H; Hindricks, G; Ibanez, B; Karam, N; Katus, H; Klok, F; Konstantinides, S; Landmesser, U; Leclercq, C; Leonardi, S; Lettino, M; Marenzi, G; Mauri, J; Metra, M; Morici, N; Mueller, C; Petronio, A; Polovina, M; Potpara, T; Praz, F; Prendergast, B; Prescott, E; Price, S; Pruszczyk, P; Rodríguez-Leor, O; Roffi, M; Romaguera, R; Rosenkranz, S; Sarkozy, A; Seferovic, P; Senni, M; Spera, F; Stefanini, G; Thiele, H; Tomasoni, D; Torracca, L; Touyz, R; Wilde, A; Williams, B
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial
2025 Docherty, K; Henderson, A; Jhund, P; Claggett, B; Desai, A; Mueller, K; Viswanathan, P; Scalise, A; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
2025 Vardeny, O; Vaduganathan, M; Claggett, B; Desai, A; Jhund, P; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Matsumoto, S; Merkely, B; Zieroth, S; Yilmaz, M; Lay-Flurrie, J; Viswanathan, P; Horvat-Broecker, A; Scalise, A; Mcmurray, J; Solomon, S
A rare case of cytomegalovirus myocarditis complicating rejection after heart transplantation: Case report and review of literature
2025 Abete, R; Iacovoni, A; Vittori, C; Sebastiani, R; Candiago, E; Gianatti, A; Terzi, A; Senni, M
Implementation of guideline-recommended medical therapy for patients with heart failure in Europe
2025 Volterrani, M; Seferovic, P; Savarese, G; Spoletini, I; Imbalzano, E; Bayes-Genis, A; Jankowska, E; Senni, M; Metra, M; Chioncel, O; Coats, A; Rosano, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Keyword
- Humans5370
- Female2972
- Male2620
- Middle Aged1884
- Adult1787
- Aged1490
- Italy1186
- COVID-191152
- Animals1033
- Nuclear and High Energy Physics742
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS1336
- PHYSICAL REVIEW LETTERS915
- JOURNAL OF HYPERTENSION792
- PHYSICS LETTERS. SECTION B699
- PHYSICAL REVIEW D571
- THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS528
- SCIENTIFIC REPORTS504
- MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY489
- PLOS ONE461
- ASTRONOMY & ASTROPHYSICS454
Editore
- Springer2392
- Elsevier B.V.2226
- Elsevier2193
- Oxford University Press2189
- Elsevier Ltd2184
- American Physical Society2027
- MDPI1942
- Elsevier BV1733
- Elsevier Inc.1299
- Lippincott Williams and Wilkins1254
Lingua
- eng72121
- ita15321
- fre374
- spa235
- por85
- ger53
- ara23
- rus14
- arc8
- chi8
Settore disciplinare
- MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE62
- M-PED/01 - PEDAGOGIA GENERALE E SOCIALE45
- M-PSI/08 - PSICOLOGIA CLINICA39
- INF/01 - INFORMATICA34
- FIS/05 - ASTRONOMIA E ASTROFISICA33
- GEO/08 - GEOCHIMICA E VULCANOLOGIA27
- ING-INF/05 - SISTEMI DI ELABORAZIONE DELLE INFORMAZIONI26
- IUS/08 - DIRITTO COSTITUZIONALE26
- CHIM/03 - CHIMICA GENERALE ED INORGANICA25
- IUS/01 - DIRITTO PRIVATO25
Tipologia
- 01 - Articolo su rivista87973
- 99 - Altro3
- 03 - Contributo in libro2
- 02 - Intervento a convegno1
Accesso al fulltext
- no fulltext49315
- open22400
- reserved14596
- partially open1594
- embargoed62
- mixed11
Progetto
- -1031
- DIP-ECC-DISAT-2018242
- DIP-ECC-MATER-2018152
- MUSA43
- DIP-ECC-FORMAZIONE-2333
- DIP-ECC-PSICOLOGIA-202323
- SWAB20
- UNIMIB-ARIA Toolkit20
- UNICORN19
- ICSC18